Table 3. Outcome indicators at 2 year follow up.
Cumulative Results at 2 Year follow-up | Overall (2493) N (%) | DM (854) N (%) | Non-DM (1639) N (%) | P value |
Lost to follow up | 7 (0.28) | 5 (0.58) | 2 (0.12) | 0.038 |
3-P MACE | 79 (3.16) | 40 (4.7) | 39 (2.4) | 0.002 |
Cardiac-Death | 34 (1.36) | 18 (2.1) | 16 (1) | 0.034 |
TV-MI | 9 (0.36) | 4 (0.5) | 5 (0.3) | 0.774 |
TLR/TVR | 36 (1.44) | 18 (2.1) | 18 (1.1) | 0.069 |
Total Stent Thrombosis | 14 (0.56) | 7 (0.8) | 7 (0.4) | 0.34 |
Definite | 10 (0.4) | 5 (0.6) | 5 (0.3) | 0.477 |
Acute stent thrombosis | 2 (0.08) | 1 (0.1) | 1 (0.1) | 0.78 |
Sub-acute stent thrombosis | 8 (0.32) | 4 (0.5) | 4 (0.2) | 0.575 |
Late stent thrombosis | 0 (0) | 0 (0) | 0 (0) | - |
Probable | 4 (0.16) | 2 (0.2) | 2 (0.1) | 0.894 |
Acute stent thrombosis | 4 (0.16) | 2 (0.2) | 2 (0.1) | 0.894 |
Sub-acute stent thrombosis | 0 (0) | 0 (0) | 0 (0) | - |
Abbreviations: TLR/TVR, target lesion/vessel revascularization; DM, diabetes mellitus; MACE, major adverse cardiovascular events; ST, stent thrombosis; TV-MI, target vessel myocardial infarction
Pvalues refer to the two subgroups.